Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9641 - 9648 of 12086 results
Breaking News: Executive Order Signed Relating to "Significant Malicious Cyber-Enabled Activities"
April 1, 2015| Blog| Viewpoint
Congressional Developments: SGR Repeal and CHIP Reauthorization
April 1, 2015| Blog| Viewpoint
Kimble and Post-Expiration Royalties: The Next Big Thing, or Much Ado About Nothing?
March 31, 2015| Alert| Viewpoint
Quick Fixes and Proposed Rulemaking for PTAB Trial Rules Announced by Director Lee
March 31, 2015| Blog| Viewpoint
President Obama Issues Executive Order on Emissions as Budgets Move Through
March 30, 2015| Blog| Viewpoint
Hospital Wins First Round Against Largest Rival in Antitrust Suit Alleging Illegal Exclusive Dealing Agreements with Insurers
March 30, 2015| Alert| Viewpoint
Antitrust Challenge to Hospital’s Exclusive Dealing Contracts with Payors Moves Forward
March 30, 2015| Blog| Viewpoint
Law360: High Court UPS Ruling Means Changes to EEOC Guidance
March 27, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|